FDA Posts Draft Guidance on Premarket Submissions for Devices
The Food and Drug Administration posted a new draft guidance on the use of national and international voluntary consensus standards in the preparation and evaluation of premarket submissions for medical devices. The draft guidance also proposes two changes in policy,…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
the first being that declarations of conformity would no longer be used when the submitter deviates from an FDA standard, and the second being that promissory statements indicating future compliance with a consensus standard would no longer be used. Comments on the draft guidance are due Aug. 11, said FDA in a concurrent Federal Register notice (here).